Member Info for CHELSEA7

Hope a good weekend has been had by all, my Chelsea surpassing any expectations i held at the start of this year and really enjoying my football this year.

It was mentioned the other day that it was hard to find too much to discuss ATM, Rays post was a good reminder of what is still being progressed, just seems to lack any idea of timelines, as indeed the SCIB1 trial and MOD1 trial are doing right now. We had £4.6min cash end APRIL this years, bolstered by £4.8m from Vulpes and tax credits, total £9.4m cash and six monts on at 400k a month cash in hand now £7m, a long way off the financial problems we have experienced so many times before.
.

I would suggest news from the left field is still very high, and funding is not the issue it has been on so many occasions before, frustrating waiting on so much news but the reasons I hold are still all there to justify that, I just didn"t expect us to hit 6p again, and the weakness in the bid threatens a 5.80 bid and 6p ask. We saw last week a few buys of some substance a 100k buy, another 100k and 55k, and 160k on Friday for the first time in many weeks, I never did top up below 7.5p before but sorely tempted at these levels, just that time of year to consider and i have a trip planned to Hungary for six weeks after New Year, to meet a fair few ""new"" family members , and see what it offers me for a few months a year, Not sure summers at 40 degrees and winters at -15 works for me though.

So hoping for some news this week, TBH I don"t need more shares now, I get that feeling from LTH too, but on the face of it possibly a good entry/reentry price for many newbies who did rather well last time out.

To a good week guys, a continuation of some solid buying and more of it will be a welcome sight and one I hooe we will see next week.

Interesting view. It seems to me that the EU want this deal to proceed, and announcing that they would refuse any delay before the event would be too obviously blunting the Benn Act, before it was actioned.

What with Letwins amendment personally I have moved from neutral/stay to a very strong leave and as far as Labour go well they are not the Party in Opposition just the Party of Disruption. Fortunately we will never see Corbyn in No 10. Just MO and good luck in your share ATB

Longterm, I am pretty sure BJ and the EU Leaders agreed on no extension when they concluded the deal

Well at least we have seen how Labour feel about Democracy, lol

Sounds like they are backing the Government............................

Ah Ruck, maybe not so Mutton Geoff?

Morning Ruck, perhaps I was still in shock over Panamas kind natured intervention?

Morning, hey as I said I accept that coming from Bermuda, I also remember Rucks question but for the life of me didn"t hear the answer, twice. Mutton Geoff as they say.

I agree Knowlesi, never heard that in the recording and I listened to it twice!!!

Well there goes that theory, lol.

Bermuda, thanks for replying, still unsure how we know no patients have been enrooled or dosed as it is not a requirement to RNS progress in that respect. Regardless of that a resubmission of the IND will have an interesting affect on the SP.

I think it was you Bermuda who firstsaid the copany are not oblifed to give a running commentary as to patients ebrolled in trial,and this is where I am having problems understanding how we can be so sure,

Anyway, have a good weekend.

Well the end of another red week, no news and none the wiser on anything.

I pomised myself I would take another 35k if we got to be 6p again, came very close today, but got the weekend to talk myself out of it. Planning on going to Hungary for 6 weeks in the New Year, so not the greatest time for me to splash the cash, but I do believe Scancell are waiting on all patients enrolled, hence screened and dosed. and because of that don"t agree with a couple of posts saying we have failed to enrol any patients so far, What happened to the patient enrolled on Aug 19th, now two months on, and in my opinion with criteria data stating life expectancy must be three months or me, they would have been dosed by now.

Understand the frustration we all feel at no news about recruitment, but we have never given out news to support the SP, an issue we have discussed so often, but I feel it doesn"t mean no patients have been enrolled or duly dosed. Funny enough I have never bought at less than 7.5p, so is it ever a good time?? At least this week we have seen volumes higher, a 100k buy, a 100k and 50k buy, same buyer I suggest ,and todays 160k £10k exactly. Crackin it took you four trades to get 50k, and then a 32k buy for 6.07 shows up and this afternoon after 14.00 we saw 83k buys in five trades and the bid never moved from MMs just taking 1k at 6p.

This is I believe the same level that Vulpes announced their stake, a subsequent rise to 10p and now retraced 40%, with a couple of signs from Scancell themselves that a new IND application for the FDA is not too far away. Wonder how the SP will react to patients dosed and IND re-submitted??

Been a very frustrating period,....again!!! and for those who haven"t read the Trinity Delta Report of the 4th September a very good reminder as to what is currently in play, a good read even for those like me who did read it and forgotten key information therein.

So have a good weekend all, personally I think we are oversold, and even then not on huge volumes, are we really worth 40% less than we were a couple of months ago?? Each to their own, no news for sure, not the same as no activity and that report reminds us of quite a few. Take Care.

For those who haven"t read it some interesting information. This I never knew....................

It is always challenging estimating the potential value of early stage technologies.
But as a reference, Scancell partnered some preclinical glycan antibodies
(generated using an earlier version of the glycan antibody platform) to the
Australian biotech company Peptech in 2006, whose CEO was at the time John
Chiplin, for an upfront payment of £2m and a milestone payment of £2.85m
(received in 2011). This suggests that Scancell could receive significant upfront
and milestone payments, with a modest royalty being payable to Nottingham
University, from out-licensing the glycan antibody platform and AvidiMab
technology, with the potential to receive additional milestones.
No changes have been made to our estimates or valuation to be conservative.
Exhibit 6: A summary of the characteristics of four TaG antibodies that Scancell aims to partner
Source: Scancell

Well worth a read............................

https://www.scancell.co.uk/Data/Sites/1/media/publications/news/scancell-update-040919_final.pdf

Buys 258k

Sells 181k

SP - 3.94%?

Well done crackin, guess that answers my question!!

Expecting a few more buys till the close!!

Four of them......presumably they are buys???

As MMs still taking just 1k shares at 6p

Buys 177k

Sells 181k

And a third 500 trade

Well it did...twice..............6/6.30

And now 6/6.20, wonder if we will see some trading at this level this afternoon??

Gap the stock, bring ask down.

Taking 27k now at 6p

Buys 177k

Sells 147k

MMs, a bit odd just taking 2k shares at 6.08